Exploring the Role of Patient Characteristics in Diabetic Medication Prescriptions: A Comprehensive Analysis

Asunciano Arce L Lomanta Jr. Md and Raman TyagiMary Rachelle R Wapaño, PhD
Additional contact information
Asunciano Arce L Lomanta Jr. Md: Medical Specialist, MHARS Medical Center, Brgy Maningco Ozamiz City, Medical Director, Diabetes Resource Center (DRC Clinic)
Raman TyagiMary Rachelle R Wapaño, PhD: Associate Dean, Graduate Studies Office, Xavier University

International Journal of Research and Scientific Innovation, 2023, vol. 10, issue 11, 644-655

Abstract: In recent times, the management of diabetes has seen an expansion in the range of available medications, necessitating a comprehensive understanding of prevailing prescription patterns and their correlation with specific patient demographics. The primary objective of this research was to examine the prevalent medication regimens for diabetic patients and discern potential variations based on factors such as age, gender, and Body Mass Index (BMI). Upon analysis of an extensive dataset, findings indicated that Metformin was the predominant medication choice, being prescribed to 76.5% of the diabetic population. However, variations in these patterns were evident. Specifically, an increased prescription of Insulin was observed among older patients and those with a higher BMI, suggesting that age and BMI might be influential determinants in medication selection for diabetes management. While this research offers a comprehensive overview of current medication trends among diabetic patients, it possesses inherent limitations due to its cross-sectional design. Such a design captures data at a singular point in time, potentially omitting evolving medication patterns or long-term drug efficacy and effects. For a more encompassing understanding, future studies are recommended to adopt a longitudinal design, monitoring patients over extended durations. Moreover, the inclusion of a broader spectrum of variables could provide deeper insights into the intricacies of diabetes management. In sum, the study emphasizes the pivotal role of personalized medicine in diabetes care. The findings advocate for prescription decisions that are tailored to individual patient characteristics, ensuring that treatment strategies remain both effective and individualized, thereby optimizing outcomes for the diabetic population.

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.rsisinternational.org/journals/ijrsi/d ... issue-11/644-655.pdf (application/pdf)
https://rsisinternational.org/journals/ijrsi/artic ... prehensive-analysis/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjc:journl:v:10:y:2023:i:11:p:644-655

Access Statistics for this article

International Journal of Research and Scientific Innovation is currently edited by Dr. Renu Malsaria

More articles in International Journal of Research and Scientific Innovation from International Journal of Research and Scientific Innovation (IJRSI)
Bibliographic data for series maintained by Dr. Renu Malsaria ().